These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33186388)

  • 1. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
    Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
    PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ; Pearce P; Herington AC; Healy DL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological differences between focal and diffuse adenomyosis and response to hormonal treatment.
    Khan KN; Fujishita A; Koshiba A; Mori T; Kuroboshi H; Ogi H; Itoh K; Nakashima M; Kitawaki J
    Reprod Biomed Online; 2019 Apr; 38(4):634-646. PubMed ID: 30850322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
    Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Masuzaki H
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():6-13. PubMed ID: 25697974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
    Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
    Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas.
    Miura S; Khan KN; Kitajima M; Hiraki K; Moriyama S; Masuzaki H; Samejima T; Fujishita A; Ishimaru T
    Hum Reprod; 2006 Oct; 21(10):2545-54. PubMed ID: 16763009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A; Vollenhoven B; Sowter M
    BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
    Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
    Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.